Roche Deutschland Holding GmbH

Germany

1 December 2017 - 30 November 2018

Principal institution: F. Hoffmann-La Roche AG

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Roche Deutschland Holding GmbH published between 1 December 2017 - 30 November 2018 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

AC FC
4 1.13

Outputs by subject (FC)

Subject AC FC
Chemistry 1 0.29
Life Sciences 3 0.85
F. Hoffmann-La Roche AG
↳ Roche Deutschland Holding GmbH
Roche S.A.S
454 Life Sciences
Anadys Pharmaceuticals, Inc.
Ariosa Diagnostics, Inc.
Bina Technologies, Inc.
Chugai Pharma USA, Inc.
Chugai Pharmabody Research Pte. Ltd.
F. Hoffmann-La Roche AG - Headquarters
Roche Innovation Center Copenhagen A/S
Roche Translational and Clinical Research Center (TCRC)
Center for Advanced Light Microscopy (CALM), Genentech, Inc.
Department of Antibody Engineering, Genentech, Inc.
Department of BioAnalytical Sciences, Genentech, Inc.
Department of BioMolecular Resources, Genentech, Inc.
Department of Biochemical and Cellular Pharmacology, Genentech, Inc.
Department of Bioinformatics and Computational Biology, Genentech, Inc.
Department of Biomedical Imaging, Genentech, Inc.
Department of Cancer Immunology, Genentech, Inc.
Department of Development Sciences, Genentech, Inc.
Department of Discovery Chemistry, Genentech, Inc.
Department of Discovery Oncology, Genentech, Inc.
Department of Drug Metabolism and Pharmacokinetics (DMPK), Genentech, Inc.
Department of Early Discovery Biochemistry, Genentech, Inc.
Department of Immunology, Genentech, Inc.
Department of Infectious Diseases, Genentech, Inc.
Department of Late Stage Pharmaceutical Development, Genentech, Inc.
Department of Microchemistry, Proteomics and Lipidomics (MPL), Genentech, Inc.
Department of Molecular Biology, Genentech, Inc.
Department of Molecular Oncology, Genentech, Inc.
Department of Neuroscience, Genentech, Inc.
Department of Oncology, Genentech, Inc.
Department of Pathology, Genentech, Inc.
Department of Physiological Chemistry, Genentech, Inc.
Department of Protein Analytical Chemistry, Genentech, Inc.
Department of Protein Chemistry and Structural Biology, Genentech, Inc.
Department of Proteomics and Biological Resources, Genentech, Inc.
Department of Safety Assessment, Genentech, Inc.
Department of Structural Biology, Genentech, Inc.
Department of Translational Immunology, Genentech, Inc.
Department of Translational Oncology, Genentech, Inc.
Genentech Research and Early Development (gRED), Genentech, Inc.
Seragon Pharmaceuticals Inc.
Small Molecule Pharmaceutical Sciences Group, Genentech, Inc.
Genia Corporation
Hoffmann-La Roche, Inc.
InterMune, Inc.
Piramed Ltd.
Roche Diabetes Care IT
Roche Diagnostics (Schweiz) AG
Roche Diagnostics Asia Pacific Pte Ltd.
Roche Diagnostics Corporation
Roche Diagnostics International AG
Roche Diagnostics S.L.
Roche Farma, S.A.
Roche Glycart AG
Roche Molecular Systems, Inc.
Roche Nederland B.V.
Roche NimbleGen, Inc.
Roche Nutley
Roche Palo Alto, LLC
Roche Pharma (Schweiz) AG
Roche Products Limited
Roche R&D Center (China) Ltd.
Roche Sequencing Solutions (RSS)
Ventana Medical Systems, Inc.
Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2019 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER